Dr. Ronda Marie Chakolis-Hassan

I think I'll start, Stan.

First of all, thank you for that wonderful introduction.

And then because I have my hands in so many things, I have to do my usual disclaimer that none of the things I'm going to talk about represent any of the entities that I either am employed by or affiliated with.

And then also, since we were here last time, I got a lot of alphabet on the last part of my name.

So it's now

chacolas hassan um that's kind of been new in the last year so i got remarried and um yeah i i think uh i think you bring out uh interesting points so one let's talk about obesity in general um we know the rates are generally going up we're actually seeing them in children african-american women also are very um

increasingly susceptible to obesity, right?

And so let's just go with the elephant in the room and talk about those medications you're talking about, the GLP-1s.

for a long time, if you think about the history of medicine and how we treat conditions, right, we've been thinking about let's have the magic bullet.

So for a while, antibiotics, penicillins, those kinds of things, those were our magic bullets.

And here we are now with this GLP run products that have the magic bullets.

First of all,

we are forgetting that sometimes medications are intended to treat one thing and have this lovely side effect.

And so the GLP ones are kind of one of those things that really kind of started out as mostly to treat diabetes, but magically,

had a side effect of weight loss.

We have medications like that.

Your Viagra and whatever initially started out as blood pressure medicines and in clinical trials didn't do so well.

And they found that they also had a side effect.

So here we are.

And I think medication is just one small portion of what we're doing.